Product Program year 2025 Source: CMS Open Payments

BD Vacutainer Buff. Na Citrate 0.109M, 3.2%

Device Diagnostic Testing

PDI 50382903630832

Open in the dashboard

General payments

$703

9 payments

Research payments

$644,166

5 payments

Through program year 2025, $703 in general payments and $644,166 in research payments were reported against BD Vacutainer Buff. Na Citrate 0.109M, 3.2% (Diagnostic Testing).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $376 6
2024 Research $643,416 4
2023 General $327 3
2023 Research $750 1

Breakdown

Who paid General payments · program years 2023–2025
  1. Becton, Dickinson and Company $703 9 payments
Top recipients General payments · program year 2025
  1. Mariam Alexander Anatomic Pathology & Clinical Pathology · Rochester, MN $226 60% · 1 payment
  2. Tatiana Belousova Anatomic Pathology & Clinical Pathology · Tupelo, MS $54 14% · 1 payment
  3. Yury Takhalov Anatomic Pathology & Clinical Pathology · Stony Brook, NY $54 14% · 1 payment
  4. Tonialatoya Wallace-Eley Anatomic Pathology & Clinical Pathology · Crystal River, FL $15 4% · 1 payment
  5. Harry Kamerow Anatomic Pathology & Clinical Pathology · State College, PA $14 4% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Anatomic Pathology & Clinical Pathology Pathology $376 100% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Minnesota $226 60% · 1 recipient
  2. Mississippi $54 14% · 1 recipient
  3. New York $54 14% · 1 recipient
  4. North Carolina $15 4% · 1 recipient
  5. Pennsylvania $14 4% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

9 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record